Skip to main content

Table 1 Demographic and baseline disease condition

From: Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)

Case

AGE

Diagnosis

Previous treatment for critical limb ischemia

Risk factors

Ischemic site/status

1

57

TAO

Minor amputation

ESH, BD

Right foot (II-4), left foot (III-5)

2

40

Diabetic foot

Minor amputation

ESH, DM

Right toe (II-4), left foot (III-5)

3

41

TAO

Sympathectomy

ESH, BD

Right foot (II-4)

4

55

TAO

Minor amputation

ESH, BD

Right foot (III-5)

5

61

Diabetic foot

Sympathectomy

DM, HC

Right foot (III-6)

6

57

TAO

Sympathectomy, major amputation

ESH, BD

Right foot (III-6)

7

66

TAO

Minor amputation, sympathectomy,

AS, BD

Right foot (III-6)

8

56

TAO

Minor amputation, sympathectomy

AS, BD

Right toe (III-5)

9

62

TAO

NO

AS, BD

Left foot (II-4)

  1. HC: Hypercholesterolemia; ESH: ex smoke habit; BD: Buerger disease; AS: active smoker; DM: diabetus mellitus; TAO: thromboangiitis obliterans